Childhood epilepsy: Management in resource-limited setting

Chhaya Valvi1, Subhashchandra Daga, Ujwala Kabade

  • 1Department of Pediatrics, B.J Medical College and Sassoon General Hospital, Pune, India.

Insights

Phenobarbital and phenytoin are effective first-line treatments for childhood epilepsy, improving seizure control. Vitamin D supplementation also supports seizure management in some cases.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Pharmacotherapy

Background:

  • Epilepsy is a neurological disorder characterized by recurrent seizures.
  • Optimizing frontline antiepileptic drug (AED) therapy is crucial for managing childhood epilepsy.
  • Phenobarbital and phenytoin are established AEDs with potential for frontline use.

Purpose of the Study:

  • To evaluate the efficacy of phenobarbital and/or phenytoin as frontline treatments for childhood epilepsy.
  • To assess the impact of these AEDs on seizure control and drug utilization.
  • To determine the role of vitamin D in managing breakthrough seizures.

Main Methods:

  • A before-and-after study design was employed at a pediatric outpatient epilepsy clinic.
  • Patient data from two cohorts (pre- and post-protocol) were compared.
  • Etiology was investigated using EEG and CT scans; serum calcium, phosphorus, and alkaline phosphatase levels were assessed.

Main Results:

  • Good seizure control improved to 84.8% post-intervention, with phenobarbital/phenytoin use increasing significantly.
  • Seven of eight children with breakthrough seizures remained seizure-free after vitamin D administration.
  • Thirteen of nineteen children on polytherapy were successfully switched to phenobarbital/phenytoin.

Conclusions:

  • Phenobarbital and/or phenytoin are effective frontline AEDs for childhood epilepsy.
  • Vitamin D administration plays a supportive role in managing certain seizure presentations.
  • This study supports the optimized use of phenobarbital and/or phenytoin in pediatric epilepsy management.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...